Diverticulitis Diagnostic Market is thriving on rising prevalence of gastrointestinal disorders
The diverticulitis diagnostic market has seen significant growth in recent years driven by the rising prevalence of gastrointestinal disorders globally. Diverticulitis refers to the inflammation or infection of small bulges or sacs that can form in the lining of the intestine. It is a common condition affecting around 10-25% of people over 60 years old. Symptoms include abdominal pain, nausea, fever and changes in bowel habits. Left untreated, diverticulitis can lead to complications like abscesses, intestinal blockage or bleeding.
Diagnosing diverticulitis involves medical history evaluation, physical examination, blood tests and imaging techniques like CT scans, ultrasound or colonoscopy. CT scans provide detailed images of the intestine and are considered the gold standard for diagnosing diverticulitis and assessing its severity. Ultrasound is also widely used as it does not use radiation. Advancements in high resolution imaging technologies have improved diagnostic accuracy for diverticulitis.
The global diverticulitis diagnostic market is estimated to be valued at US$ 1.2 Billion in 2030 and is expected to exhibit a CAGR of 5.5% over the forecast period 2025-2030.
Key Takeaways
Key players operating in the diverticulitis diagnostic market are GE Healthcare, Shimadzu Corporation, Siemens Healthineers, Carestream Health, Fujifilm Holdings Corporation.
Growing health awareness and significant increase in elderly population prone to gastrointestinal disorders are fueling the demand for early and accurate diverticulitis diagnosis globally.
Major players are expanding their geographic footprint in emerging markets of Asia Pacific and Latin America. Fujifilm launched portable ultrasound machine W380 in 2021 tailored forPOINT-OF-CARE applications in rural areas.
Market Key Trends
Development of advanced imaging techniques is a major trend in the diverticulitis diagnostic market. GE Healthcare launched LOGIQ E10 ultrasound scanner in 2022 with enhanced spectral Doppler imaging for superior vascular flow visualization. This aids in diagnosis of complications involving blood vessels. Shimadzu introduced ASCENDUS CT system with 3D modeling capabilities for comprehensive assessment of diverticulitis lesions and impacted tissue regions.
Another notable trend is growing adoption of artificial intelligence (AI) in diverticulitis diagnosis. Startups like Anthropic are developing AI platforms to automate CT scan analysis for diverticulitis. This can help improve diagnostic accuracy and consistency especially for junior radiologists. Wider adoption of AI powered technologies is expected in the coming years to make diverticulitis diagnostic more efficient, accessible and affordable.
Porter’s Analysis
Threat of new entrants: Low capital requirement and low brand recognition barriers make it easy for new companies to enter the market. However, the established market leadership of major players creates barriers.
Bargaining power of buyers: Buyers have moderate to high bargaining power. They can negotiate lower prices from established manufacturers due to availability of substitutes.
Bargaining power of suppliers: Suppliers of raw materials have low bargaining power due to availability of substitute materials and suppliers. Manufacturers can change suppliers if prices increase.
Threat of new substitutes: Pharmaceutical companies constantly invest in R&D to develop new and improved treatment options. This poses a threat of substitution.
Competitive rivalry: The market is dominated by few large players. Pricing competition and new product launches increase rivalry between manufacturers.
Geographical Regions
North America currently holds the largest share of the global diverticulitis market, primarily due to increasing healthcare expenditure and growing elderly population in the region which is more prone to diverticulitis.
Asia Pacific region is poised to grow at the fastest rate over the forecast period. This is attributed to growing economies, rising healthcare spending, and increasing awareness about diverticulitis treatment in countries like China and India.
What Are The Key Data Covered In This Diverticulitis Diagnostic Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Diverticulitis Diagnostic ‘s growth between 2024 and 2031.
:- Accurate calculation of the size of the Diverticulitis Diagnostic and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Diverticulitis Diagnostic Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market’s competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Diverticulitis Diagnostic vendors
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
